165 related articles for article (PubMed ID: 2254030)
1. Mechanism of pertussis toxin B oligomer-mediated protection against Bordetella pertussis respiratory infection.
Shahin RD; Witvliet MH; Manclark CR
Infect Immun; 1990 Dec; 58(12):4063-8. PubMed ID: 2254030
[TBL] [Abstract][Full Text] [Related]
2. Protective activities in mice of monoclonal antibodies against pertussis toxin.
Sato H; Sato Y
Infect Immun; 1990 Oct; 58(10):3369-74. PubMed ID: 1698179
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Bordetella pertussis infection with monoclonal antibodies to pertussis toxin.
Halperin SA; Issekutz TB; Kasina A
J Infect Dis; 1991 Feb; 163(2):355-61. PubMed ID: 1703192
[TBL] [Abstract][Full Text] [Related]
4. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.
Kimura A; Mountzouros KT; Relman DA; Falkow S; Cowell JL
Infect Immun; 1990 Jan; 58(1):7-16. PubMed ID: 2294058
[TBL] [Abstract][Full Text] [Related]
5. Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system.
Sato H; Sato Y
Infect Immun; 1984 Nov; 46(2):415-21. PubMed ID: 6542069
[TBL] [Abstract][Full Text] [Related]
6. Immune response to the B oligomer of pertussis toxin.
Arciniega JL; Burns DL; Garcia-Ortigoza E; Manclark CR
Infect Immun; 1987 May; 55(5):1132-6. PubMed ID: 3570457
[TBL] [Abstract][Full Text] [Related]
7. Relationship between structure and biological and protective activities of pertussis toxin.
Sato H; Sato Y
Dev Biol Stand; 1991; 73():121-32. PubMed ID: 1723387
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of antibodies elicited by immunization with pertussis toxin.
Kaslow HR; Schlotterbeck JD; Gotto J
Dev Biol Stand; 1991; 73():143-50. PubMed ID: 1778308
[TBL] [Abstract][Full Text] [Related]
9. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge model.
Bruss JB; Siber GR
Clin Diagn Lab Immunol; 1999 Jul; 6(4):464-70. PubMed ID: 10391844
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections.
Sato H; Ito A; Chiba J; Sato Y
Infect Immun; 1984 Nov; 46(2):422-8. PubMed ID: 6094351
[TBL] [Abstract][Full Text] [Related]
12. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
Sato H; Sato Y
Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
[TBL] [Abstract][Full Text] [Related]
13. Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection.
Shahin RD; Amsbaugh DF; Leef MF
Infect Immun; 1992 Apr; 60(4):1482-8. PubMed ID: 1548072
[TBL] [Abstract][Full Text] [Related]
14. Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice.
Oda M; Cowell JL; Burstyn DG; Manclark CR
J Infect Dis; 1984 Dec; 150(6):823-33. PubMed ID: 6094673
[TBL] [Abstract][Full Text] [Related]
15. Mucosal and systemic immune responses elicited by recombinant Lactococcus lactis expressing a fusion protein composed of pertussis toxin and filamentous hemagglutinin from Bordetella pertussis.
Torkashvand A; Bahrami F; Adib M; Ajdary S
Microb Pathog; 2018 Jul; 120():155-160. PubMed ID: 29738814
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the B oligomer to the protective activity of genetically attenuated pertussis toxin.
Arciniega JL; Shahin RD; Burnette WN; Bartley TD; Whiteley DW; Mar VL; Burns DL
Infect Immun; 1991 Oct; 59(10):3407-10. PubMed ID: 1894354
[TBL] [Abstract][Full Text] [Related]
17. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
Watanabe M; Nagai M
Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
[TBL] [Abstract][Full Text] [Related]
19. Quantitative priming with inactivated pertussis toxoid vaccine in the aerosol challenge model.
Bruss JB; Siber GR
Infect Immun; 2002 Aug; 70(8):4600-8. PubMed ID: 12117973
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis.
Roduit C; Bozzotti P; Mielcarek N; Lambert PH; del Giudice G; Locht C; Siegrist CA
Infect Immun; 2002 Jul; 70(7):3521-8. PubMed ID: 12065491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
